It has been shown, that A2BR antagonism reduces differentiation and suppressive capacity of Tregs and suppressive myeloid cells, leading to an increased presence of tumour-infiltrating CD8+ T cells in vivo [23, 25, 26, 70]. Here, CD8A is linked to neoplasm.